Published in Proc Natl Acad Sci U S A on August 24, 2015
Autonomous membrane IgE signaling prevents IgE-memory formation. Nat Immunol (2016) 0.83
Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host. Front Microbiol (2016) 0.78
Animal models of tumorigenic herpesviruses-an update. Curr Opin Virol (2015) 0.75
Mouse model for acute Epstein-Barr virus infection. Proc Natl Acad Sci U S A (2016) 0.75
LMP1 and LMP2A collaborate to promote Epstein-Barr virus (EBV)-induced B cell lymphomas in a cord blood-humanized mouse model but are not essential. J Virol (2017) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63
Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature (1985) 14.39
Epstein-Barr virus: 40 years on. Nat Rev Cancer (2004) 9.70
Intraclonal generation of antibody mutants in germinal centres. Nature (1991) 7.39
A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res (2003) 6.76
Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem (1999) 6.67
Germinal centers. Annu Rev Immunol (2012) 6.26
Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol (1990) 6.23
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell (1995) 5.97
EBV persistence in memory B cells in vivo. Immunity (1998) 4.44
Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med (2006) 3.16
In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells. J Exp Med (1993) 3.13
Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity (1998) 3.10
B cell receptor signal strength determines B cell fate. Nat Immunol (2004) 3.06
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity (2000) 2.96
Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity (1995) 2.74
Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One (2010) 2.67
ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol (2006) 2.63
Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science (1999) 2.61
Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol (2009) 2.43
An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci U S A (1994) 2.38
Antigen-driven B cell differentiation in vivo. J Exp Med (1993) 2.35
EBV and systemic lupus erythematosus: a new perspective. J Immunol (2005) 2.34
Molecular characterization of single memory B cells. Nature (1991) 2.16
Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development. Immunity (2008) 2.11
The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology (1997) 2.03
Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J Virol (1993) 1.94
Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J Pathol (1997) 1.72
Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet (1971) 1.60
Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell (2012) 1.59
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood (2007) 1.50
Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol (2004) 1.45
Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. J Virol (2000) 1.38
Acute complications of Epstein-Barr virus infectious mononucleosis. Curr Opin Pediatr (2000) 1.38
The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J Virol (2000) 1.30
IntPath--an integrated pathway gene relationship database for model organisms and important pathogens. BMC Syst Biol (2012) 1.28
Adjuvant-specific regulation of long-term antibody responses by ZBTB20. J Exp Med (2014) 1.25
The BTB-ZF transcription factor Zbtb20 is driven by Irf4 to promote plasma cell differentiation and longevity. J Exp Med (2014) 1.21
Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis. J Exp Med (1981) 1.17
The NF-κB genomic landscape in lymphoblastoid B cells. Cell Rep (2014) 1.12
Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog (2011) 1.10
Positive feedback within a kinase signaling complex functions as a switch mechanism for NF-κB activation. Science (2014) 1.05
Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan. Med Microbiol Immunol (2004) 1.01
Latent membrane protein 2A, a viral B cell receptor homologue, induces CD5+ B-1 cell development. J Immunol (2004) 1.01
Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice. PLoS Pathog (2012) 1.00
A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc (2008) 1.00
Impairment of organ-specific T cell negative selection by diabetes susceptibility genes: genomic analysis by mRNA profiling. Genome Biol (2007) 0.98
Autoimmunity to cardiolipin in infectious mononucleosis. Lancet (1987) 0.97
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro. J Virol (2006) 0.96
Persistence of Epstein-Barr virus in self-reactive memory B cells. J Virol (2012) 0.93
Activation-induced cytidine deaminase expression in CD4+ T cells is associated with a unique IL-10-producing subset that increases with age. PLoS One (2011) 0.89
Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation. Virology (2004) 0.88
Protein kinase N1, a cell inhibitor of Akt kinase, has a central role in quality control of germinal center formation. Proc Natl Acad Sci U S A (2012) 0.85
Differentiation and maintenance of long-lived plasma cells. Curr Opin Immunol (2015) 0.84
B-cell receptor signal strength influences terminal differentiation. Eur J Immunol (2013) 0.80